The platelet count in 110 patients with subarachnoid hemorrhage (SAH) was analyzed retrospectively . Changes in the platelet count in 102 patients undergoing intracranial aneurysm surgery showed that the minimum platelet count was similar in patients with and without symptomatic vasospasm , but the minimum occurred later in symptomatic vasospasm patients, regardless of Hunt and Hess grade or operation timing. Sixty-five of 67 non-symptomatic vasospasm patients (97%) showed the minimum platelet count within 4 days of SAH and two (3%) on the 5th day. In contrast, only 10 of 35 symp tomatic vasospasm patients (29%) showed a minimum platelet count within 4 days after SAH and 25 (71%) between the 5th and 11th days. Analysis of the eight patients not receiving surgery showed that the minimum platelet count occurred 2 days after SAH in two non-symptomatic vasospasm patients , but after the 5th day in five of six symptomatic vasospasm patients. Therefore, monitoring of the platelet count can provide an indicator of the occurrence of symptomatic vasospasm.
Introduction
Cerebral vasospasm following subarachnoid hemor rhage (SAH) may cause delayed ischemic deteriora tion, resulting in disability or death of the patient."') The etiology and pathogenesis of cerebral vasospasm after SAH are unclear, preventing the development of effective treatment. However, earlier prediction of the onset of symptomatic vasospasm (SV) might allow prophylactic therapy to be effective. 1, 12) Aggregation of platelets on the damaged en dothelium of arteries around ruptured intracranial aneurysms has been observed,9) and adventitial blood causes intimal platelet accumulation in cerebral arteries. 14) Some intraluminal platelet con sumption may occur in cerebral arteries after SAH. Platelets contain a number of vasoactive substances which can cause contraction of vascular smooth mus cle, including thromboxane A2, noradrenaline, 5 hydroxytryptamine, and platelet-derived growth fac tor. 2-4,10,11) Therefore, the release of various substances from the aggregating platelets will then promote further platelet aggregation and local vasoconstriction.9)
In this study, we analyzed the sequential changes in the platelet count in 110 SAH patients to assess whether platelet count is a predictor of SV.
Clinical

Materials and Methods
This retrospective study included 110 of 166 SAH pa tients with ruptured cerebral aneurysms admitted to the Department of Neurosurgery of Toyama Medical and Pharmaceutical University between January 1, 1985 to December 31, 1990. Fifty-six patients were ex cluded, because they died within 4 days of SAH, were admitted more than 4 days after SAH, or devel oped delayed neurological deterioration due to hydrocephalus or other hemorrhagic lesions. The 110 patients consisted of 38 males and 72 fe males, aged 35-86 years (median, 56.86 yrs). They were divided into two groups by presence or ab sence of SV (SV and non-SV groups). SV was de fined as a delayed neurological deterioration such as hemiparesis and aphasia occurring more than 4 days after SAH. Table 1 shows the clinical status graded on admission according to the Hunt and Hess scale,') the location of the ruptured aneurysm, timing of surgery after SAH, and the outcome at discharge according to the Glasgow Outcome Scale.') Sequential changes in platelet counts, including the minimum count and the day of minimum count, were compared between the SV and non-SV groups. Hematocrit values were also analyzed simultaneously to exclude hemoconcentration or hemodilution effects on the platelet count. No patient received aspirin, nonsteroidal anti-inflammatory drugs, or anti-platelet agents such as ticlopidine. 102 of the 110 patients underwent intracranial aneurysm sur gery, and were divided into four groups according to Hunt and Hess grade and operation timing ( Table  2) . Eight patients were treated conservatively.
To evaluate the effect of surgery on the platelet count, we surveyed an additional 55 patients who had operations for neurosurgical conditions other than SAH between January 1, 1990 and December 31, 1990. Twelve patients (8 males and 4 females, aged 38-72 yrs with a median of 57.0 yrs) had brain tumors, 12 (7 males and 5 females, aged 49-87 yrs with a median of 66.7 yrs) had hypertensive in tracerebral hematomas, 16 (11 males and 5 females, aged 17-75 yrs with a median of 50.6 yrs) had traumatic intracranial hematomas, and 15 (3 males and 12 females, aged 33-66 yrs with a median of 54.1 yrs) had various other neurosurgical conditions. Data were expressed as means ± SEM, and ana lyzed using Student's t-test to compare the mini mum platelet counts, and the Wilcoxon U test to compare the distribution of the day of minimum platelet count. Thirty-five SV and 67 non-SV patients received surgery. The platelet count in these patients showed an early decrease followed by an increase, reached the maximum between days 10 and 16 postictus, and thereafter gradually fell again (Fig. 1) . The minimum occurred later in the SV patients than in the non-SV patients in all four groups (p < 0.01) (Fig. 2) . In non-SV patients, the minimum platelet count occur red within 4 days of SAH in 65 (97%) and on the 5th day in two (3%). In contrast, the minimum in SV pa tients was within 4 days of SAH in 10 (29%) and be tween the 5th and 11th days in 25 (71 %). However, the minimum platelet counts in the non-SV (16.1 ± 0.60 x 104/mm3, n = 67) and the SV groups (15.2 ± 0.80 x 104/mm3, n = 35) showed no sig nificant difference (0.05 < p < 0.25). The sequential changes in hematocrit values showed no correlation with platelet variation. Platelet counts in the patients receiving operations for other conditions showed that all patients (100%) with brain tumors, 92% with hypertensive in tracerebral hematoma, 94% with traumatic in tracranial hematoma, and 93% with other neurosurgical conditions demonstrated a minimum platelet count within 4 days of operation. Only one of 67 non-SV patients (1%) had a minimum platelet count more than 5 days after operation. In contrast, 18 of 35 SV patients (51%) had a minimum more than 5 days after operation.
Five SV patients demonstrated a minimum within 4 days of operation and a second, lower minimum later (data not shown). The other SV patients had the minimum count be tween the 5th and 16th days after operation.
Two non-SV and six SV patients did not have surgery. The minimum platelet count occurred 2 days after SAH in the two non-SV patients (data not shown). In contrast, the six SV patients showed a delayed minimum platelet count (on the 3rd day in 1 patient, 5th day in 1, 6th day in 2, 7th day in 1, and 8th day in 1) (Fig. 3) . Table 2 . Table 2 . 
